NCT03960177View on ClinicalTrials.gov

Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma

EARLY_PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

March 27, 2019

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Osteosarcoma

Interventions

DRUG

Glucarpidase

Given IV

OTHER

Quality-of-Life Assessment

Ancillary studies

Trial Locations (3)

19104

University of Pennsylvania/Abramson Cancer Center, Philadelphia

97239

OHSU Knight Cancer Institute, Portland

32224-9980

Mayo Clinic in Florida, Jacksonville

Sponsors

Collaborators (1)

BTG International Inc.

All Listed Sponsors

collaborator

BTG International Inc.

OTHER

collaborator

Oregon Health and Science University

OTHER

lead

OHSU Knight Cancer Institute

OTHER